Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Sponsor Directory

Dana-Farber Cancer Institute clinical trials

Sponsor pages show live ClinicalTrials.gov search results and objective aggregate stats only. They do not describe sponsor quality, reputation, or expected outcomes.

ClinicalTrials.gov public records Last synced May 21, 2026, 1:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials
391
Shown on this page
0
Local recruiting
72
Top conditions
6
The trial list below is retrieved from the live ClinicalTrials.gov search API for sponsor Dana-Farber Cancer Institute. Results on this page are currently sorted by Recently updated.

Filter and sort this sponsor

These controls apply only within Dana-Farber Cancer Institute. Default order is Recently updated. Add condition, therapy, location, or recruitment status to narrow this sponsor page further.

Reset sponsor filters
Clear filters
No matching trials for sponsor Dana-Farber Cancer Institute with the current filters.
Indexed local directory records.

Top conditions

Breast Cancer 57 Prostate Cancer 28 Ovarian Cancer 21 Pancreatic Cancer 16 Multiple Myeloma 13 Leukemia 12

Top locations

Boston, Massachusetts 388 New York, New York 34 Houston, Texas 28 San Francisco, California 17 Chicago, Illinois 17 Philadelphia, Pennsylvania 16

Top therapies

Cyclophosphamide 18 Nivolumab 15 Pembrolizumab 14 Dexamethasone 10 Docetaxel 10 Paclitaxel 10
Directory status

No official records matched this sponsor search.

Try broadening the condition, therapy, location, or status filters to search a wider set of public records within this sponsor.

About this Dana-Farber Cancer Institute sponsor directory page

What this page lists
U.S. ClinicalTrials.gov public records where Dana-Farber Cancer Institute is the lead sponsor, including recruiting, not yet recruiting, and active not recruiting trials across phase 1, phase 2, and phase 3.
How to narrow results
Use the filters above to scope by condition, intervention, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, age, or NCT ID within Dana-Farber Cancer Institute trials.
Where the data comes from
Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do
No medical advice, eligibility judgments, sponsor quality scoring, ranking of trials, or AI-generated medical summaries.

Related: all sponsor pages, browse by condition, browse by drug or therapy, browse by U.S. city, or open the full search for Dana-Farber Cancer Institute.